CalPERS leaders shared their 2025 to-do lists, which includes improving investment portfolio outcomes, awarding a new pharmacy benefits contract for 2026, a full review of all actuarial assumptions, and more.
At the annual Stakeholder Forum, Chief Executive Officer Marcie Frost, Chief Investment Officer Stephen Gilmore, Chief Clinical Director Dr. Julia Logan, and Deputy Chief Actuary Fritzie Archuleta discussed their long-term desired outcomes, along with short-term strategies to reach such goals.